Alitair Pharmaceuticals
2010
FOUNDED
PRIVATE
STATUS
Angel
LATEST DEAL TYPE
$5M
LATEST DEAL AMOUNT
Description
Developer of respiratory drugs designed to treat bronchiectasis. The company's drugs can be utilized across a range of therapeutic classes and with many different molecules for the treatment of respiratory illnesses, enabling medical professionals to treat bronchiectasis easily and patients to get relief from respiratory related diseases quickly.
Website
Formerly Known As
The Cough Company
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
- 55 Madison Avenue
- Suite 400
- Morristown, NJ 07960
- United States
+1 (940) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Alitair Pharmaceuticals’s full profile, request a free trial.
Alitair Pharmaceuticals Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Angel (individual) | 29-Jun-2017 | $5M | 00.00 | Completed | Generating Revenue | |
| 2. Angel (individual) | 10-Feb-2017 | 00000 | 00000 | Completed | Generating Revenue | |
| 1. Angel (individual) | 29-Sep-2015 | $911K | Completed | Generating Revenue |
Alitair Pharmaceuticals Executive Team (5)
Alitair Pharmaceuticals Board Members (3)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| James Hoyes | Alitair Pharmaceuticals | Co-Chief Executive Officer & Board Member | 000 0000 | |
| Robert Casale | Alitair Pharmaceuticals | Board Member | 000 0000 | |
| William Howard Ph.D | Alitair Pharmaceuticals | Co-Chief Executive Officer, President & Chairman | 000 0000 |